From: Platelet-rich plasma for tendinopathy and osteoarthritis: a narrative review
Study | Diagnosis | Patients | F up | Results |
---|---|---|---|---|
Auriemma et al. (2020) [26] | Hamstring tendinopathy | 22 | 6 months | ≥ 50% reduction of pain, functional outcomes improved |
Scott et al. (2019) [34] | Patellar tendinopathy | 61 | 12 months | No more effective than saline for the improvement of symptoms. |
Levy et al. (2018) [35] | Hamstring tendinopathy | 29 | 8 weeks | No improvement on clinical outcomes |
Liu et al (2019) [36] | Achilles tendinopathy | 189 | – | Not superior to placebo treatment |
Ibrahim et al. (2018) [37] | rotator cuff tendinopathy | 30 | 7 weeks | A significant improvement of pain, SDQ and ROM |
Chen et al. (2020) [38] | Rotator cuff tears | 1116 | – | Retear rates were significantly decreased |
Linnanmäki et al. (2020) [39] | Lateral epicondylitis | 119 | 52 weeks | no improved pain or function |
Huang et al. (2020) [40] | Elbow epicondylitis and plantar fascitiis | 1268 | – | Long-term functional improvement |
Alkhatib et al. (2020) [41] | Plantar fasciitis | 389 | – | Effective and safe treatment option |
Lin et al. (2020) [42] | Rotator cuff tendinopathy | 283 | 24 weeks | Effective in reducing pain in the long term (over 2 weeks) |